Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: Safety and efficacy results of a phase i first-in-man study

Human Gene Therapy Clinical Development

Volumn 24, Issue 3, 2013, Pages 99-107

  Spanggaard, Iben ^a   Snoj, Marko ^b   Cavalcanti, Andrea ^c   Bouquet, Céline ^d   Sersa, Gregor ^b   Robert, Caroline ^c   Cemazar, Maja ^b   Dam, Elisabeth ^d   Vasseur, Bérangère ^d   Attali, Pierre ^d   Mir, Lluis M ^c,e,f   Gehl, Julie ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d BioAlliance Pharma   (France)

^e CNRS   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEINS; AGED; ANGIOGENESIS INHIBITORS; ELECTROPORATION; FEMALE; GENETIC THERAPY; HUMANS; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; SKIN NEOPLASMS; TRANSFECTION; TREATMENT OUTCOME;

EID: 84898869622     PISSN: 23248637     EISSN: 23248645     Source Type: Journal    
DOI: 10.1089/humc.2012.240     Document Type: Article

References (29)